skip to main content

Yellow Card reporting — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

EasyAdverse Drug Reactions and SafetyYellow Card reportingGPhC CRA

A patient develops angioedema after starting an ACE inhibitor and is admitted to hospital. The pharmacy team asks whether this should be reported. What is the most appropriate action?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: E — Submit a Yellow Card report and document the allergy/adverse reaction

Serious suspected adverse drug reactions should be reported through the Yellow Card scheme. Causality does not need to be proven. The patient's record should be updated to prevent re-exposure.

Reference: MHRA Yellow Card; GPhC Standards